Biologically Potent Analogues of the DMT-TIC Pharmacophore and Methods of Use Read more about Biologically Potent Analogues of the DMT-TIC Pharmacophore and Methods of Use US Application 60/834,438Filed on 2006-07-31
Mouse Systems For Evaluating Antiviral Agent Toxicity Read more about Mouse Systems For Evaluating Antiviral Agent Toxicity US Application 60/699,413Filed on 2005-07-14
Novel Glycated Peptides And Proteins To Serve As Biomarkers For Diabetes Control Read more about Novel Glycated Peptides And Proteins To Serve As Biomarkers For Diabetes Control US Application 60/779,710Filed on 2006-03-06
DMT-DERIVATIVE COMPOUNDS AND RELATED COMPOSITIONS AND METHODS OF USE Read more about DMT-DERIVATIVE COMPOUNDS AND RELATED COMPOSITIONS AND METHODS OF USE US Application 60/714,071Filed on 2005-09-01
Targeting ABCA13 Transporter to Control Hyperlipidema. Read more about Targeting ABCA13 Transporter to Control Hyperlipidema. US Application 60/731,380Filed on 2005-10-28
Glyceraldehyde 3-phosphate Dehydrogenase-S (GAPDS), A Glycolytic Enzyme Expressed Only In Male Germ Cells Is A Target For Male Contraception Read more about Glyceraldehyde 3-phosphate Dehydrogenase-S (GAPDS), A Glycolytic Enzyme Expressed Only In Male Germ Cells Is A Target For Male Contraception US Application 60/429,638Filed on 2002-11-27
New Biological Potent Analogues Of The DMT-TIC Pharmaphore And Methods Of Use71 Read more about New Biological Potent Analogues Of The DMT-TIC Pharmaphore And Methods Of Use71 US Application 60/628,147Filed on 2004-11-16
Methods Related to the Treatment of Inflammatory Conditions Read more about Methods Related to the Treatment of Inflammatory Conditions US Application 60/570,566Filed on 2004-05-12
Thermostable UvrA, UvrB, Adn UvrC Polypeptides And Methods Of Use Read more about Thermostable UvrA, UvrB, Adn UvrC Polypeptides And Methods Of Use US Application 60/311,336Filed on 2001-08-10
Soluble Epoxide HydrolaseInhibitors as Novel Therapeutic Agents for Management of Systemic Hypertension Read more about Soluble Epoxide HydrolaseInhibitors as Novel Therapeutic Agents for Management of Systemic Hypertension US Application 60/023,397Filed on 1996-08-13